Rigel Pharmaceuticals (RIGL) Posts Wider than Expected Q4 Loss of 36c/Share
Tweet Send to a FriendGet Alerts RIGL Hot Sheet
Price: $3.85 +2.12%
Revenue Growth %: -100.0%
Financial Fact:
Interest income: 136K
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -100.0%
Financial Fact:
Interest income: 136K
Today's EPS Names:
ATU, CRWS, CLC, More
Trade RIGL Now!
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q4 EPS of ($0.36), $0.08 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- Actuant Corp. (ATU) Tops Q3 EPS by 3c; Trims FY13 Outlook, Guides FY14
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
